Titan Medical Inc. (TMDI)

NASDAQ: TMDI · IEX Real-Time Price · USD
0.555
+0.047 (9.28%)
Jul 1, 2022 12:17 PM EDT - Market open

Company Description

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery.

It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.

The company is headquartered in Toronto, Canada.

Titan Medical Inc.
Titan Medical Logo
Country Canada
Industry Health Care Equipment & Supplies
Sector Health Care
Employees 49
CEO David McNally

Contact Details

Address:
170 University Ave
Toronto, Ontario M5H 3B3
Canada
Phone 416 548 7522
Website titanmedicalinc.com

Stock Details

Ticker Symbol TMDI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0000840551
CUSIP Number 88830X819
ISIN Number CA88830X8199
SIC Code 8731

Key Executives

Name Position
Paul G. Cataford B.Sc., M.B.A. Chairman, Interim Chief Executive Officer and Pres
Stephen L. Lemieux BA, CA, CPA, MMPA Chief Financial Officer
Jasminder Brar Vice President of Legal, IP and Strategic Initiatives, Corporate Secretary and General Counsel
Kristen P. Galfetti Vice President of Investor Relations and Corporate Communications
Tammy Barnes Carrea Vice President of Quality and Regulatory Affairs

Latest SEC Filings

Date Type Title
Jun 9, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 9, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 6, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 1, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
May 18, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
May 12, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
May 6, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
May 3, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 28, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 26, 2022 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]